Article information
Full text is only aviable in PDF
REFERENCES
[1]
WHO.
Travel by air: health considerations.
Wkly Epidemiol Rec, 21 (2005), pp. 181-191
[2]
Aeropuertos Espanoles y Navegacion Aerea (AENA).
Aeropuertos. Estadisticas. (Cited 2006 Feb 17).
[3]
A Johnson.
Flying with respiratory disease.
Breath, 42 (1993), pp. 2-5
[4]
RO Cummins, PJ Chapman, DA Chamberlain, JA Schubach, PE Iitwin.
Inflight deaths during commercial air travel. How big a problem?.
JAMA, 259 (1988), pp. 1983-1988
[5]
JR Hordinsky, MH George.
Utilization of emergency kits by air carriers, FAA Civil Aeromedical Institute, (1991),
[6]
JR Hordinsky, MH George.
Response capability during civil air carrier inflight medical emergencies, FAA Civil Aeromedical Institute, (1991),
[7]
British Thoracic Society Standards for Care Committee.
Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations. 2004. [Cited 2005 Nov 26].
[8]
MedAire.
Health and Security. Expert care, everywhere. [Cited 2005 Nov 26].
[9]
British Thoracic Society.
Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations.
Thorax, 57 (2002), pp. 289-304
[10]
American Thoracic Society.
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 152 (1995), pp. S78-S83
[11]
D Iien, M Turner, the Canadian Thoracic Society Standards Committee.
Recommendations for patients with chronic respiratory disease considering air travel: a statement from the Canadian Thoracic Society.
Can Respir J, 5 (1998), pp. 95-100
[12]
Aerospace Medical Association, Medical Guidelines Task Force, Alexandria.
Medical guidelines for airline travel. 2nd ed..
Aviat Space Environ Med, 74 (2003), pp. A1-A19
[13]
BR Celli, W MacNee, committee members of ATS/ERS task force.
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.
Eur Respir J, 23 (2004), pp. 932-946
[14]
Aerospace Medical Association.
Medical oxygen and air travel.
Aviat Space Environ Med, 71 (2000), pp. 827-831
[15]
Aerospace Medical Association.
Inflight medical emergencies.
Aviat Space Environ Med, 71 (2000), pp. 832-838
[16]
Air Transport Medicine Committee, Aerospace Medical Association.
Medical guidelines for airline travel, Aerospace Medical Association, (1997),
[17]
J Emsting, AR Nicholson, DJ Rainford.
Aviation Medicine, 3rd ed., Butterworth Heinmann, (1999),
[18]
World Health Organization.
TB and air travel: guidelines for prevention and control, WHO, (1998),
[19]
H Gong.
Advising patients with pulmonary diseases on air travel.
Ann Intern Med, 111 (1989), pp. 349-351
[20]
R deHart.
Fundamentals of Aerospace Medicine, 2nd ed., Williams & Wilkins, (1996),
[21]
F Rios Tejada.
Modificaciones fisiopatologicas y psicopatologicas en la altitud y su significado en medicina aeronautica. [Tesis Doctoral], Universidad Complutense, (1998),
[22]
EH Hunt, DH Reid, DR Space, FE Tilton.
Commercial airliner environmental. Control system engineering aspects of cabin air quality. [Cited 2005 Nov 26].
[23]
Hunt EH, Space MR. The airplane cabin environment. Issues pertaining to flight attendant comfort. [Cited 2005 Nov 26] Available from: http://www.boeing.com/commercial/cabinanyventilation.pdf
[24]
RK Coker, MR Partridge.
What happens to patients with respiratory disease when they fly?.
Thorax, 59 (2004), pp. 919-920
[27]
F Rfos Tejada, A Azofra Garcia.
Patologia pulmonar en grandes alturas.
Enfermedades respiratorias, pp. 685-693
[28]
TA Dillard, BW Berg, KR Rajagopal, JW Dooley, WJ Mehm.
Hypoxaemia during air travel in patients with chronic obstructive pulmonary disease.
Ann Intern Med, 111 (1989), pp. 362-367
[29]
JJ Cottrell.
Altitude exposures during aircraft flights: flying higher.
Chest, 92 (1988), pp. 81-84
[30]
JA Aldrete, LE Aldrete.
Oxygen concentrations in commercial aircraft flights.
South Med J, 76 (1983), pp. 12-14
[31]
H Gong.
Air travel and oxygen therapy in cardiopulmonary patients.
Chest, 101 (1992), pp. 1104-1113
[32]
JS Schwartz, HZ Bencowitz, KM Moser.
Air travel hypoxemia with chronic obstructive pulmonary disease.
Ann Intern Med, 100 (1984), pp. 473-477
[33]
MD Ibanez Cuerda, E Servera Pieras.
El pulmon y los viajes en avion.
Arch Bronconeumol, 31 (1995), pp. 526-533
[34]
LM Seccombe, MJ Peters.
Oxygen supplementation for chronic obstructive pulmonary disease patients during air travel.
Curr Opin Pulm Med, 12 (2006), pp. 140-144
[35]
AMA Commission on Emergency Medical Services.
Medical aspects of transportation aboard commercial aircraft.
JAMA, 247 (1982), pp. 1007-1011
[36]
A Akero, CC Christensen, A Edvardsen, OH Skjonsberg.
Hypoxaemia in chronic obstructive pulmonary disease patients during a commercial flight.
Eur Respir J, 25 (2005), pp. 725-730
[37]
AC Guyton.
Textbook of medical physiology, 8th ed., pp. 463-476
[38]
V Essebag, AR Halabi, M Churchill-Smith, S Lutchemedial.
Air medical transport of cardiac patients.
Chest, 124 (2003), pp. 1937-1945
[39]
JJ Cottrell, BL Iebovitz, RG Fennell, GM Kohn.
Inflight arterial saturation: continuous monitoring by pulse oximetry.
Aviat Space Environ Med, 66 (1995), pp. 126-130
[40]
JF Nunn.
Applied Respiratory Physiology, 3rd ed., Butterworth & Co, (1987),
[41]
KP Vohra, RA Klocke.
Detection and correction of hypoxemia associated with air travel.
Am Rev Respir Dis, 148 (1993), pp. 1215-1219
[42]
NM Apte, DR Karnad.
Altitude hypoxaemia and the arterial-to-alveolar oxygen ratio.
Ann Intern Med, 112 (1990), pp. 547-548
[44]
I Malagon, R Grounds, E Bennett.
Changes in cardiac output during air ambulance repatriation.
Intensive Care Med, 22 (1996), pp. 1396-1399
[45]
GE Gale, JR Toire-Bueno, RE Moon, HA Saltzman, PD Wagner.
Ventilation-perfusion inequality in normal humans during exercise at sea level and simulated altitude.
J Appl Physiol, 58 (1985), pp. 978-988
[46]
RB Schoene.
Limits of human lung function at high altitude.
J Exp Biol, 204 (2001), pp. 3121-3127
[47]
JB West, PD Wagner.
Predicted gas exchange on the summit of Mt.
Everest. Respir Physiol, 42 (1980), pp. 1-16
[48]
P Ward.
High altitude medicine and physiology, Chapman & Hall Medical, (1989),
[49]
E Hohenhaus, A Paul, RE McCullough, H Kucherer, P Bartsch.
Ventilatory and pulmonary vascular response to hypoxia and susceptibility to high altitude pulmonary edema.
Eur Respir J, 8 (1995), pp. 1825-1833
[50]
PD Wagner, GE Gale, RE Moon, JR Torre-Bueno, BW Stolp, HA Saltzman.
Pulmonary gas exchange in humans exercising at sea level and simulated altitude.
J Appl Physiol, 61 (1986), pp. 260-270
[51]
PD Wagner, JR Sutton, JT Reeves, A Cymerman, BM Groves, MK Malconian.
Operation Everest II: pulmonary gas exchange during a simulated ascent of Mt.
Everest. J Appl Physiol, 63 (1987), pp. 2348-2359
[52]
JR Torre-Bueno, PD Wagner, HA Saltzman, GE Gale, RE Moon.
Diffusion limitation in normal humans during exercise at sea level and simulated altitude.
J Appl Physiol, 58 (1985), pp. 989-995
[53]
SC Kanick, WJ Doyle.
Barotrauma during air travel: predictions of a mathematical model.
J Appl Physiol, 98 (2005), pp. 1592-1602
[54]
Cabin Pressurization. United States Naval Flight Surgeon's Manual. 3rd ed. Physiology of Flight. Naval Aerospace Medical Institute. [Cited 2005 Nov 26] Available from: http://www.vnh.org/FSManual/01/06CabinPress.html
[55]
Trapped Gas. United States Naval Flight Surgeon's Manual. 3rd ed. Physiology of Flight. Naval Aerospace Medical Institute. [Cited 2005 Nov 26] Available from: http://www.vnh.org/FSManual/01/08TrappedGas.html
[56]
WM Boothby, WRIT Iovelace, OO Benson Jr, AF Strehler.
Volume and partial pressures of respiratory gases at altitude.
Handbook of respiratory physiology,
[57]
RK Coker, MR Partridge.
Assessing the risk of hypoxia in flight: the need for more rational guidelines.
Eur Respir J, 15 (2000), pp. 128-130
[58]
R Rodriguez-Roisin, A Garcia-Navarro, F Burgos Rincon, P Casan Clara, M Perpina Tordera, L Sanchez Agudo, et al.
Recomendacion SEPAR sobre gasometria arterial.
Arch Bronconeumol, 34 (1998), pp. 142-153
[59]
J Sanchis Aldas, P Casan Clara, J Castillo Gomez, N Gonzalez Mangado, L Palenciano Ballesteros, J Roca Torrent.
Espirometria forzada.
Recomendaciones SEPAR, pp. 1-18
[60]
MR Miller, J Hankinson, V Bmsasco, F Burgos, R Casaburi, A Coates, et al.
ATS/ERS task force: Standardisation of lung function testing. Standardization of spirometry.
Eur Respir J, 26 (2005), pp. 319-338
[61]
N Maclntyre, RO Crapo, G Viegi, DC Johnson, CPM van der Grinten, V Bmsasco, et al.
ATS/ERS task force: Standardisation of lung function testing. Standardisation of the single-breath determination of carbon monoxide uptake in the lung.
Eur Respir J, 26 (2005), pp. 720-735
[62]
American Thoracic Society.
ATS Statement: Guidelines for the six-minute walk test.
Am J Respir Crit Care Med, 166 (2002), pp. 111-117
[63]
CC Chistensen, M Ryg, OK Refvem, OH Skjonsberg.
Development of severe hypoxaemia in COPD patients at 2438 m (8000 ft) altitude.
Eur Respir J, 15 (2000), pp. 635-639
[64]
EK Cotton, M Hiestand, GE Philbin, M Simmons.
Reevaluation of birth weights at high altitude.
Am J Obstet Gynecol, 138 (1980), pp. 220-222
[65]
H Gong Jr, DP Tashkin, EY Lee, MS Simmons.
Hypoxia-altitude simulation test. Evaluation of patients with chronic airway obstruction.
Am Rev Respir Dis, 130 (1989), pp. 980-986
[66]
TA Dillard, AP Rosenberg, BW Berg.
Hypoxaemia during altitude exposure. A meta-analysis of chronic obstructive pulmonary disease.
Chest, 103 (1993), pp. 422-425
[67]
H Gong, DP Tashkin, EY Iee, MS Simmons.
Hypoxia-altitude simulation test.
Am Rev Respir Dis, 130 (1984), pp. 980-986
[68]
JN Henry, LJ Krenis, RT Cutting.
Hypoxaemia during aeromedical evacuation.
Surg Gynecol Obstet, 136 (1973), pp. 49-53
[69]
TA Dillard, LK Moores, KL Bilello, YY Phillips.
The preflight evaluation. A comparison of the hypoxia inhalation test with hypobaric exposure.
Chest, 107 (1995), pp. 352-357
[70]
MJ Muhm.
Predicted arterial oxygenation at commercial aircraft cabin altitudes.
Aviat Space Environ Med, 75 (2004), pp. 905-912
[71]
CC Christensen, M Ryg, OK Refvem, OH Skjonsberg.
Effect of hypobaric hypoxia on blood gases in patients with restrictive lung disease.
Eur Respir J, 20 (2002), pp. 300-305
[72]
LM Seccombe, PT Kelly, CK Wong, PG Rogers, S Iim, MJ Peters.
Effect of simulated commercial flight on oxygenation in patients with interstitial lung disease and chronic obstructive pulmonary disease.
Thorax, 59 (2004), pp. 966-970
[73]
KP Vohra, RA Klocke.
Detection and correction of hypoxemia associated with air travel.
Am Rev Respir Dis, 148 (1993), pp. 1215-1219
[74]
BJB Grant, HZ Bencowitz, AT Aquilina, AR Saltzman, RA Klocke.
Air transportation of patients with acute respiratory failure: theory.
Aviat Space Environ Med, 58 (1987), pp. 645-651
[75]
PD Wagner, DR Dantzker, R Dueck, JL Clausen, JB West.
Ventilation-perfusion inequality in chronic obstructive pulmonary disease.
J Clin Invest, 59 (1977), pp. 203-216
[76]
D Cramer, S Ward, D Geddes.
Assessment of oxygen supplementation during air travel.
Thorax, 51 (1996), pp. 202-203
[77]
DP Johns, JS Streeton, PD Rochford.
An air-entrainment device for preparing precision gas mixtures.
J Med Eng Technol, 3 (1983), pp. 140-143
[78]
SJ Barker, KK Tremper.
The effect of carbon monoxide inhalation on pulse oximetry and transcutaneous PO2.
Anesthesiology, 66 (1987), pp. 677-679
[79]
WJ Mehm, TA Dillard, BW Berg, JW Dooley, KR Rajagopal.
Accuracy of oxyhemoglobin saturation monitors during simulated altitude exposure of men with chronic obstructive pulmonary disease.
Aviat Space Environ Med, 62 (1991), pp. 418-421
[80]
M Naughton, P Rochford, J Pretto, RJ Pierce, NF Cain, LB Irving.
Is normobaric simulation of hypobaric hypoxia accurate in chronic airflow limitation?.
Am J Respir Crit Care Med, 152 (1995), pp. 1956-1960
[81]
S Finkelstein, JF Tomashefski, FH Shillito.
Pulmonary mechanics at altitude in normal and obstructive lung disease patients.
Aerospace Med, 36 (1965), pp. 880-884
[82]
G Coates, G Gray, A Mansell, C Nahmias, A Powles, J Sutton, et al.
Changes in lung volume, lung density, and distribution of ventilation during hypobaric decompression.
J Appl Physiol, 46 (1979), pp. 752-755
[83]
RM Buchdahl, A Babiker, A Busch, D Cramer.
Predicting hypoxaemia during flights in children with cystic fibrosis.
Thorax, 56 (2001), pp. 877-879
[84]
BE Berg, TA Dillard, KR Rajagopal, WJ Mehm.
Oxygen supplementation during air travel in patients with chronic obstructive pulmonary disease.
Chest, 101 (1992), pp. 638-641
[85]
Stonehill RB, Peoples AG. The accuracy of venturi masks at altitude. A viat Space Environ Med. 192;53:818-21.
[86]
MR Kramer, DJ Jakobson, C Springer, Y Donchin.
The safety of air transportation of patients with advanced lung disease. Experience with 21 patients requiring lung transplantation or pulmonary tromboendarterectomy.
Chest, 108 (1995), pp. 1292-1296
[88]
TA Dillard, WA Beninati, BW Berg.
Air travel in patients with chronic obstructive pulmonary disease.
Arch intern Med, 151 (1991), pp. 1793-1795
[89]
A Mortazavi, MJ Eisenberg, D Iangleben, P Ernst, RL Schiff.
Altitude-related hypoxia: risk assessment and management for passengers on commercial aircraft.
Aviat Space Environ Med, 74 (2003), pp. 922-927
[90]
WGB Graham, CS Houston.
Short-term adaptation to moderate altitude.
JAMA, 240 (1978), pp. 1491-1494
[91]
H Matthys, H Volz, H Ernst, N Konietzko, HR Kleeberg.
Kardiopulmonale belastung von flagpassagierien mit obstruktiven ventilationsstorungen.
Schweiz Med Wochenschr, 104 (1974), pp. 1786-1789
[92]
C Speizer, C Rennie, H Breton.
Prevalence of in-flight medical emergencies on commercial airlines.
Ann Emerg Med, 18 (1989), pp. 26-29
[93]
BW Berg, TA Dillard, SS Derderian, KR Rajagopal.
Hemodynamic effects of altitude exposure and oxygen administration in chronic obstructive pulmonary disease.
Am J Med, 94 (1993), pp. 407-412
[94]
TA Kenyon, SE Valway, WW Ihle, IM Honorato, KG Castro.
Transmission of multidrug resistant Mycobacterium tuberculosis during a long airplane flight.
N Engl J Med, 334 (1996), pp. 933-938
[95]
WHO.
Revision of the international health regulations.
Wkly Epidemiol Rec, 77 (2002), pp. 157-164
[96]
LO Gostin.
International infectious disease law. Revision of the world health organization's international health regulations.
JAMA, 291 (2004), pp. 2623-2627
[97]
International travel and health.
Situation as on 1 January 2005, WHO, (2005),
[98]
I Gammaitoni, MC Nucci.
Using a mathematical model to evaluate the efficacy of TB control measures.
Emerg Infect Dis, 3 (1997), pp. 335-342
[99]
United States General Accounting Office. Aviation safety: more research needed on the effects of air quality on airliner cabin occupants. [Cited 2005 Sept 26] January 2004, Washington, DC Available from: http://www.gao.gov/new.items/d0454.pdf
[100]
G Ko, KM Thompson, EA Nardell.
Estimation of tuberculosis risk on a commercial airliner.
Risk Anal, 24 (2004), pp. 379-388
[101]
A Mangili, M Gendreau.
Transmission of infectious diseases during commercial air travel.
Lancet, 365 (2005), pp. 989-996
[102]
S Olsen, HI Chang, TY Cheung, AF Tang, TL Fisk, SP Ooi, et al.
Transmission of severe acute respiratory syndrome on aircraft.
N Engl J Med, 349 (2003), pp. 2416-2422
[103]
MR Moser, TR Bender, HS Margolis, GR Noble, AP Kendal, DG Ritter.
An outbreak of influenza aboard a commercial airline.
Am J Epidemiol, 110 (1979), pp. 1-6
[104]
D Ozonoff, L Pepper.
Ticket to ride: spreading germs a mile high.
Lancet, 365 (2005), pp. 917-919
[105]
El Pai's, August 26 2005: p. 5.
[106]
CR Driver, SE Valway, WM Morgan, IM Onorato, KG Castro.
Transmission of Mycobacterium tuberculosis associated with air travel.
Lancet, 342 (1993), pp. 112-113
[107]
JW McFarland, C Hickman, MT Osterholm, KL MacDonald.
Exposure to Mycobacterium tuberculosis during air travel.
Lancet, 342 (1993), pp. 112-113
[108]
Centers for Disease Control and Prevention (CDC).
Exposure of passengers and flight crew to Mycobacterium tuberculosis on commercial aircraft, 1992-1995.
MMWR, 44 (1995), pp. 137-140
[109]
MA Miller, S Valway, IM Honorato.
Tuberculosis risk after exposure on airplanes.
Tubercl Lung Dis, 77 (1996), pp. 414-419
[110]
M Moore, KS Fleming, L Sands.
A passenger with pulmonary/laryngeal tuberculosis: no evidence of transmission on two short flight.
Aviat Space Environ Med, 67 (1996), pp. 1097-1100
[111]
S Valway, J Watson, C Bisgard, L Scudeller, M Espinal, M Raviglione.
Tuberculosis and air travel. Guidelines for prevention and control. WHO/TB98.256, World Health Organization, (1998),
[112]
World Health Organization.
Update 62. -more than 8000 cases reported globally, situation in Taiwan, date on in-flight transmission, report on Henan province, China. [Cited 2005 Sept 26] Geneva: WHO, 2003.
[113]
Consensus document on the epidemiology of severe acute respiratory syndrome (SARS). WHO/CDS/CSR/GAR/2003. [Cited 2005 Sept 26] Available from: http://www.who.int/csr/sars/en/WHOconsensus.pdf
[114]
WHO recommended measures for persons undertaking international travel from areas affected by severe acute respiratory syndrome (SARS). [Cited 2005 Sept 26].
Wkly Epidemiol Rec, 14 (2003), pp. 97-120
[115]
World Health Organization.
Summary of SARS and air travel. [Cited 2005 Sept 26], WHO, (2003),
[116]
A Wilder-Smith, H Leong, J Villacian.
In flight transmission of severe acute respiratory syndrome vims (SARS): a case report.
J Travel Med, 10 (2003), pp. 299-300
[117]
M Mutsch, M Tavemini, A Marx, V Gregory, Y Pu Lin, AJ Hay, et al.
Influenza vims infection in travelers to tropical and subtropical countries.
Clin Infect Dis, 40 (2005), pp. 1282-1287
[118]
KC Klontz, NA Hynes, RA Gunn, MH Wilder, MW Harmon, AP Kendal.
An outbreak of influenza A/Taiwan 1/86 (H1N1) infections at a naval base and its association with airplane travel.
Am J Epidemiol, 129 (1989), pp. 341-348
[119]
VL Iaurel, CC de Witt, YA Geddie, MC Yip, DM Dolan, LC Canas, et al.
An outbreak of influenza A caused by imported vims en United States, Julyl999.
Clin Infect Dis, 32 (2001), pp. 1639-1642
[120]
J Perz, AS Craig, W Schaffner.
Mixed outbreak of parainfluenza type 1 and influenza B associated with tourism and air travel.
J Infect Dis, 5 (2001), pp. 189-191
[122]
Centers for Disease Control and Prevention.
Specific recommendations for vaccination and disease prevention: influenza.
Health information for international travel, 1999-2000, pp. 104-106
[123]
Centers for Disease Control and Prevention.
Exposure to patients with meningococcal disease on aircraft -United States, 1999-2001.
MMWR, 50 (2001), pp. 485-489
[124]
RW Amler, AB Bloch, WA Orenstein, KJ Bart, PM Turner Jr, AR Hinman.
Imported measles in the United States.
JAMA, 248 (1982), pp. 2129-2133
[125]
PN Arnomful, H Takahashi, AK Bogard, M Nakata, R Harpaz, PV Effler.
Low risk of measles transmission after exposure on an international airline light.
J Infect Dis, 189 (2004), pp. S81-S85
[126]
Centers for Disease Control and Prevention.
Epidemiological notes and reports. Interstate importation of measles following transmission in an airport-California, Washington, 1982.
MMWR, 32 (1983), pp. 210-216
[127]
Centers for Disease Control and Prevention.
Epidemiological notes and reports. Multistate investigation of measles among adoptees from China.
MMWR, 53 (2004), pp. 309-310
[128]
JN Zitter, PD Mazonson, DP Miller, SB Hulley, JR Balmes.
Aircraft cabin air recirculation and symptoms of the common cold.
JAMA, 288 (2002), pp. 483-486
[129]
J Gillis.
U.S. to Triple Airport Quarantine Stations. Health Program Aims to Prevent Infectious Diseases From Entering Country.
Washington Post Staff Writer, (August 28, 2005), pp. 16
[130]
RJ Pitman, BS Cooper, CL Trotter, NJ Gay, WJ Edmunds.
Entry screening for severe acute respiratory syndrome (SARS) or influenza: policy evaluation.
[131]
RJ Webby, RG Webster.
Are we ready for pandemic influenza?.
Science, 302 (2003), pp. 1519-1522
[132]
KW Tsang, Ph Eng, CK Liam, YS Shim, WK Lam.
H5N1 influenza pandemic: contingency plans.
Lancet, 366 (2005), pp. 533-534
[133]
R Fouchier, T Kuiken, G Rimmelzwaan, A Osterhaus.
Global task force for influenza.
Nature, 435 (2005), pp. 419-420
[134]
J Bartlet, FG Hayden.
Influenza A (H5N1). Will it be the next pandemic influenza. Are we really?.
Ann Int Med, 143 (2005), pp. 460-462
[135]
A Trampuz, RM Prabhu, TF Smith, LM Baddour.
Aviar influenza. A new pandemic threat?.
Mayo Clin Proc, 79 (2004), pp. 523-530
[136]
Responding to the avian pandemic influenza threat. Recommended strategic action. WHO/CDS/CSR/GIP/2005. [Cited 2005 Sept 26].
[137]
WHO Global influenza preparedness plan. The role of WHO and recommendations for national measures before and during pandemics. [Cited 2005 Sept 26] WHO/CDS/CSR/GIP/2005.5 Available from: http://www.who.int/csr/resources/publications/influenza/WHO_CDS_CSR_GIP_2005_5.pdf
[138]
PJ Oades, RM Buchdhal, A Bush.
Prediction of hipoxaemia at high altitude in children with cystic fibrosis.
BMJ, 308 (1994), pp. 15-18
[139]
O Thews, B Fleck, WE Kamin, DE Rose.
Respiratory function and blood gas variables in cystic fibrosis patients during reduced environmental pressure.
Eur J Appl Physiol, 92 (2004), pp. 493-497
[140]
R Fischer, SM Iang, K Bruckner, HX Hoyer, S Meyer, M Griese, et al.
Lung function in adults with cystic fibrosis at altitude: impact on air travel.
Eur Respir J, 25 (2005), pp. 718-724
[141]
AK Webb.
Flying cystic fibrosis: getting there and back safely.
Thorax, 56 (2001), pp. 821-822
[142]
ME Speechly-Dick, SJ Rimmer, ME Hodson.
Exacerbations of cystic fibrosis after holidays at high altitude-a cautionary tale.
Respir Med, 86 (1992), pp. 55-56
[143]
WE Kamin, B Fleck, D Rose.
Intensified physiotherapy improves fitness to fly in cystic fibrosis patients.
Eur J Med Res, 5 (2000), pp. 402-404
[144]
RH White.
The epidemiology of venous thromboembolism.
Circulation, 107 (2003), pp. 14-18
[145]
JA Heit, WM O'Fallon, TM Petterson, CM Lohse, MD Silverstein, DN Mohr, et al.
Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study.
Arch Intern Med, 162 (2002), pp. 1245-1248
[146]
MM Samama.
An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study.
Arch Intern Med, 160 (2000), pp. 3415-3420
[147]
F Uresandi, J Blanquer, F Conget, MA de Gregorio, JL Lobo, R Otero, et al.
Normativa SEPAR. Gufa para el diagnostico, tratamiento y seguimiento de la tromboembolia pulmonar.
Arch Bronconeumol, 40 (2004), pp. 580-594
[148]
J Homans.
Thrombosis of the deep leg veins due to prolonged sitting.
N Engl J Med, 250 (1954), pp. 148-149
[149]
IS Symington, BH Stack.
Pulmonary thromboembolism after travel.
Br J Dis Chest, 71 (1977), pp. 138-140
[150]
F Rfos Tejada, F Villegas Fernandez, JA Azofra Garcia, L Callol Sanchez.
Smdrome del pasajero de clase economica.
An Med Interim, 19 (2002), pp. 589-593
[151]
BF Jacobson, M Munster, A Smith, KG Bumand, A Carter, AT Abdool-Carrim, et al.
The BEST study - a prospective study to compare business class versus economy class air travel as a cause of thrombosis.
S Afr Med J, 93 (2003), pp. 522-528
[152]
E Ferrari, T Chevallier, A Chapelier, M Baudouy.
Travel as a risk factor for venous thromboembolic disease: a case-control study.
Chest, 120 (2001), pp. 1047-1048
[153]
B Bendz, M Rostrup, K Sevre, TO Anderson, PM Sandset.
Association between acute hypobaric hypoxia and activation of coagulation in human beings.
Lancet, 356 (2000), pp. 1657-1658
[154]
W Schobersberger, D Fries, M Mittermayr, P Innerhofer, G Sumann, B Schobersberger, et al.
Changes of biochemical markers and functional tests for clot formation during long-haul flights.
Thromb Res, 108 (2002), pp. 19-24
[155]
PD Hodkinson, BJ Hunt, K Parmar, J Emsting.
Is mild normobaric hypoxia a risk factor for venous thromboembolism?.
J Thromb Haemost, l (2003), pp. 2131-2133
[156]
G Belcaro, G Geroulakos, AN Nicolaides, KA Myers, M Winford.
Venous thromboembolism from air travel: the LONFLIT study.
Angiology, 52 (2001), pp. 369-374
[157]
T Schwarz, G Siegert, W Oettler, K Halbritter, J Beyer, R Frommhold, et al.
Venous thrombosis after long-haul flights.
Arch Intern Med, 163 (2003), pp. 2759-2764
[158]
RJ Hughes, RJ Hopkins, S Hill, M Weatherall, WN Van de, M Nowitz, et al.
Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study.
Lancet, 362 (2003), pp. 2039-2044
[159]
F Paganin, A Bourde, JL Yvin, R Genin, JL Guijarro, A Bourdin, et al.
Venous thromboembolism in passengers following a 12-h flight: a case-control study.
Aviat Space Environ Med, 74 (2003), pp. 1277-1280
[160]
Clerel, G Caillard.
Thromboembolic syndrome from prolonged sitting and flights of long duration experience of the Emergency Medical Service of the Paris Airports.
Bull Acad Natl Med, 993 (1999), pp. 985-997
[161]
F Iapostolle, V Surget, SW Borron, M Desmaizieres, D Sordelet, C Iapandry, et al.
Severe pulmonary embolism associated with air travel.
N Engl J Med, 345 (2001), pp. 779-783
[162]
E Perez-Rodriguez, D Jimenez, G Diaz, I Perez-Walton, M Luque, C Guillen, et al.
Incidence of air travel-related pulmonary embolism at the Madrid-Barajas airport.
Arch Intern Med, 163 (2003), pp. 2766-2770
[163]
WH Geerts, GF Pineo, JA Heit, D Bergqvist, MR Iassen, CW Colwell, et al.
Prevention of venous thromboembolism. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Chest, 126 (2004), pp. 338S-400S
[164]
R Arya, JA Barnes, U Hossain, RK Patel, AT Cohen.
Long-haul flights and deep vein thrombosis: a significant risk only when additional factors are also present.
Br J Haematol, 116 (2002), pp. 653-654
[165]
AJ Schreijer, SC Cannegieter, JC Meijers, S Middeldorp, HR Buller, FR Rosendaal.
Activation of coagulation system during air travel: a crossover study.
Lancet, 37 (2006), pp. 832-838
[166]
G Belcaro, MR Cesarone, SS Shah, AN Nicolaides, G Geroulakos, E Ippolito, et al.
Prevention of edema, flight microangiopathy and venous thrombosis in long flights with elastic stockings. A randomised trial: The LONFLIT 4 Concorde Edema-SSL Study.
Angiology, 53 (2002), pp. 635-645
[167]
G Belcaro, MR Cesarone, AN Nicolaides, A Ricci, G Geroulakos, SS Shah, et al.
Prevention of venous thrombosis with elastic stockings during long-haul flights: the LONFLIT 5 JAP study.
Clin Appl Thromb Haemost, 9 (2003), pp. 197-201
[168]
MR Cesarone, G Belcaro, AN Nicolaides, L Incandela, S De, G Geroulakos, et al.
Venous thrombosis from air travel: the LONFLIT 3 study - prevention with aspirin vs low-molecular-weight heparin (LMWH) in high-risk subjects: a randomised trial.
Angiology, 53 (2002), pp. 1-6
[169]
GV Belcaro, MR Cesarone, A Nicolaides.
Prevention of flight venous trombosis in high risk subjects with stockings or one-dose enoxaparin [abstract].
Circulation, 106 (2002), pp. 721
[170]
F Smeets.
Travel techonology-dependent patients with respiratory disease.
Thorax, 49 (1994), pp. 77-81
[171]
JK Stoller.
Oxygen and Air Travel.
Respir Med, 45 (2000), pp. 214-221
[174]
JS Noble, JA Davidson.
Cor pulmonale presenting in a patient with congenital kyphoscoliosis following intercontinental air travel.
Anaesthesia, 54 (1999), pp. 361-363
[175]
WJM Kinnear.
Assisted ventilation at home, Medical Publications, (1994),
[176]
A Qureshi, KM Porter.
Emergencies in the air.
Emerg Med J, 22 (2005), pp. 658-659
[177]
M Gendreau, C DeJohn.
Responding to medical events during commercial airline flights.
N Engl J Med, 346 (2002), pp. 1067-1073
[178]
B Iara, M Miravitlles.
Viajar con oxigeno. Reflexiones a proposito de la primera reunion international de pacientes con deficit de alfa-1 antitripsina.
Arch Bronconeumol, 40 (2004), pp. 140-144
[179]
JK Stoller, E Hoisington, G Auger.
A comparative analysis of arranging in-flight oxygen aboard commercial air carriers.
Chest, 115 (1999), pp. 991-995
[180]
British Lung Foundation.
Air travel with a lung condition. [Cited Nov 26, 2005].
[181]
California Thoracic Society.
Safe flying for people with lung disease. [Cited Nov 26, 2005].
[182]
Aerospace Medical Association.
Medical guidelines for airline passengers. [Cited Nov, 26, 2005].
Copyright © 2007. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
